 |
|
ADHD medications do not cause genetic damage in children
November 20, 2008In contrast to recent findings, two of the most common medications used to treat attention deficit hyperactivity disorder (ADHD) do not appear to cause genetic damage in children who take them as prescribed, according to a new study by researchers at the National Institutes of Health (NIH) and Duke University Medical Center.
The study published online this month in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) provides new evidence that therapeutic doses of stimulant medications, such as methylphenidate and amphetamine, do not cause cytogenetic (chromosomal) damage in humans. The researchers looked at three measures of cytogenetic damage in white blood cells of each child participating in the study and found no evidence of any changes after three months of continuous treatment.
"This is good news for parents," said Kristine L. Witt, M.Sc., a genetic toxicologist at the National Institute of Environmental Health Sciences (NIEHS) and co-author on the study, which was funded through the Best Pharmaceuticals for Children Act by NIEHS and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both parts of NIH. "Our results indicate that methylphenidate- and amphetamine-based products do not induce cytogenetic damage in children."
The researchers involved emphasize that the findings should not be interpreted as final proof of the long-term safety of stimulant drugs for the treatment of ADHD. "More research and close monitoring of children taking these medications for extended periods of time is needed to fully evaluate the physical and behavioral effects of prolonged treatment with stimulants," noted Scott H. Kollins, Ph.D., director of the Duke ADHD Program, where the study was conducted and a co-author of the paper.
ADHD is a disorder characterized by attention problems, impulsivity, and hyperactivity. About 3 to 5 percent of children in the United States have been diagnosed with the disorder, although several studies suggest 7 to 12 percent of children may be affected.
The current study included 63 children, ranging from 6-12 years of age, who met full criteria for ADHD but who had not previously been treated with stimulant medications. Children in the study were divided into two groups and treated by a board-certified child psychiatrist with either methylphenidate (commercially available as Ritalin LA and Concerta) or with mixed amphetamine salts (Adderall and Adderall XR). Blood samples were taken before the medication was started to establish baseline values for the cytogenetic measures that were analyzed in the study, and a second sample was collected after three months of continuous treatment. Forty-seven children completed the full three-month treatment schedule.
The researchers found no significant differences between the two groups of children with regard to age, gender, race, body weight, height, or ADHD subtype. The groups also showed very similar ADHD symptom levels at initial screening and children in both groups responded equally well to the medication.
The researchers looked at three standard indicators of chromosomal damage: structural chromosomal aberrations (breaks in chromosomes), micronuclei (small nuclei consisting of chromosome fragments produced by breakage or whole chromosomes lost from the main nucleus after the cell divides), and sister chromatid exchanges (exchanges of genetic material between a pair of identical chromosomes). "We did not see any significant treatment-related increases in any of these three endpoints," said Donald R. Mattison, M.D., senior advisor to the director at NICHD. "These results add to a growing body of evidence that therapeutic levels of these medications do not damage chromosomes," he said.
The study was designed to determine the reproducibility of findings from a previously published paper that reported methylphenidate-induced chromosomal changes in children with ADHD. That paper raised concern for the medical community and parents, given that some of the changes have been associated with an increased risk of cancer. The current study was not able to replicate the findings from the previous study. The new JAACAP paper extends the literature by using a larger sample size than previous studies, investigating more than one commonly prescribed medication, and providing well-characterized results that can be generalized to other ADHD populations.
"One way scientists evaluate each other's work is by attempting to reproduce the original experiment or study," said Witt. "We designed a study with specific modifications to address issues raised with the original study. Thus, our results are based on a significantly larger number of children who were carefully evaluated using rigorous, accepted standards, which allowed us to produce high-confidence data at the end of our study."
NIH/National Institute of Environmental Health Sciences
The researchers involved emphasize that the findings should not be interpreted as final proof of the long-term safety of stimulant drugs for the treatment of ADHD. "More research and close monitoring of children taking these medications for extended periods of time is needed to fully evaluate the physical and behavioral effects of prolonged treatment with stimulants," noted Scott H. Kollins, Ph.D., director of the Duke ADHD Program, where the study was conducted and a co-author of the paper.
ADHD is a disorder characterized by attention problems, impulsivity, and hyperactivity. About 3 to 5 percent of children in the United States have been diagnosed with the disorder, although several studies suggest 7 to 12 percent of children may be affected.
The current study included 63 children, ranging from 6-12 years of age, who met full criteria for ADHD but who had not previously been treated with stimulant medications. Children in the study were divided into two groups and treated by a board-certified child psychiatrist with either methylphenidate (commercially available as Ritalin LA and Concerta) or with mixed amphetamine salts (Adderall and Adderall XR). Blood samples were taken before the medication was started to establish baseline values for the cytogenetic measures that were analyzed in the study, and a second sample was collected after three months of continuous treatment. Forty-seven children completed the full three-month treatment schedule.
The researchers found no significant differences between the two groups of children with regard to age, gender, race, body weight, height, or ADHD subtype. The groups also showed very similar ADHD symptom levels at initial screening and children in both groups responded equally well to the medication.
The researchers looked at three standard indicators of chromosomal damage: structural chromosomal aberrations (breaks in chromosomes), micronuclei (small nuclei consisting of chromosome fragments produced by breakage or whole chromosomes lost from the main nucleus after the cell divides), and sister chromatid exchanges (exchanges of genetic material between a pair of identical chromosomes). "We did not see any significant treatment-related increases in any of these three endpoints," said Donald R. Mattison, M.D., senior advisor to the director at NICHD. "These results add to a growing body of evidence that therapeutic levels of these medications do not damage chromosomes," he said.
The study was designed to determine the reproducibility of findings from a previously published paper that reported methylphenidate-induced chromosomal changes in children with ADHD. That paper raised concern for the medical community and parents, given that some of the changes have been associated with an increased risk of cancer. The current study was not able to replicate the findings from the previous study. The new JAACAP paper extends the literature by using a larger sample size than previous studies, investigating more than one commonly prescribed medication, and providing well-characterized results that can be generalized to other ADHD populations.
"One way scientists evaluate each other's work is by attempting to reproduce the original experiment or study," said Witt. "We designed a study with specific modifications to address issues raised with the original study. Thus, our results are based on a significantly larger number of children who were carefully evaluated using rigorous, accepted standards, which allowed us to produce high-confidence data at the end of our study."
NIH/National Institute of Environmental Health Sciences
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Metabolism Brain Region Surface Tension Semiconductor Blood-brain Barrier Quark Electrons Cyclones Anxiety Disorders Quality Of Life Circumcision Eye Movement Glucose Stem Cell Transplant Autoimmune Algal Blooms Hurricanes Snoring Solar Cells Antarctic Aurora Robotics Weight Gain Embryonic Stem Cells Cancer Patient
See More: Science News Tags
ADHD Current Events and ADHD News RSSADHD genes found, known to play roles in neurodevelopment
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD.
Measuring intellectual disability
Researchers from the University of California, Davis have developed a specific and quantitative means of measuring levels of the fragile X mental retardation 1 (FMR1) protein (FMRP), which is mutated in fragile X syndrome.
Could hormones explain gender differences in neurological disease?
Neurological diseases including Parkinson's, Tourette's, attention deficit hyperactivity disorder (ADHD), Alzheimer's, and schizophrenia are all associated with alterations in dopamine-driven function involving the dopamine transporter (DAT).
MIT: Long-distance brain waves focus attention
Just as our world buzzes with distractions - from phone calls to e-mails to tweets - the neurons in our brain are bombarded with messages.
History of hyperactivity off-base, says researcher
A Canadian researcher working in the U.K. says doctors, authors and educators are doing hyperactive children a disservice by claiming that hyperactivity as we understand it today has always existed.
Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find
As thousands of students nationwide prepare to leave high school, a UC Davis study appearing online today in the June issue of the medical journal Pediatrics shows a clear link between attention problems early in school - as early as kindergarten - and lower high school test scores.
Cognition already seriously impaired in first episode of schizophrenia
Significant and widespread cognitive problems appear to exist in schizophrenia in its earliest phase, making it very hard for people with the disorder to work, study or be social, according to a new study published by the American Psychological Association.
OHSU researchers study the idling brain
Oregon Health & Science University researchers, along with scientists at Washington University in St. Louis, are uncovering new information about the mind by studying the brain while it is at rest.
Hypertensive kids more likely to have learning/attention problems
Children who have high blood pressure are more likely to have learning disabilities and attention deficit hyperactivity disorder (ADHD) than children who are not hypertensive.
Study links ADHD with sleep problems in adolescents
A study in the May 1 issue of the journal SLEEP shows that adolescents with a childhood diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD) are more likely to have current and lifetime sleep problems and disorders, regardless of the severity of current ADHD symptoms.
More ADHD Current Events and ADHD News Articles
 |
Parenting Children With Adhd: 10 Lessons That Medicine Cannot Teach (APA Lifetools) by Vincent J., Ph.D. Monastra (Author) Kids with ADHD need to be loved and shown how to become successful adults. Unfortunately, their lack of attention and restlessness often get in the way. Parents of these kids try so hard to stay connected and remain patient in the face of daily frustration. However, it is an incredible challenge to remain positive and involved when your child does not respond to the kinds of strategies that work for other children. Without guidance and systematic treatment, these bright, inquisitive children are unlikely to graduate from high school, are more prone to use illegal drugs, and struggle to maintain employment as adults. Parenting Children with ADHD: Lessons That Medicine Cannot Teach gives parents a framework for building a successful parenting program at home. Drawing from his experiences in... |
 |
Adult ADHD: Regaining Focus It is not diagnosed by any blood test or x-ray and it has even been dismissed as nothing more than laziness or a lack of focus. But for millions of adults, Attention Deficit, Hyperactivity Disorder, (ADHD) is a real, life altering condition. Once thought to be just a childhood issue, ADHD is now found in many stages of life, and effects men and women equally. In Adult ADHD: Regaining Focus patients describe how ADHD has altered their lives, and share how they have worked to overcome its effects. Leading medical experts in the field explain how the human brain misfires in people with ADHD and what new treatment options are helping adults finally gain control over this condition. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will... |
 |
Attend by Vaxa for ADD AdHd Homeopathy Attention - 60 ct by Vaxa The Reticular Activating System and its connections. At the center of consciousness, attention and learning. The Reticular Activating System appears to be intimately involved in the neural mechanisms which produce consciousness and focused attention, receiving impulses from the spinal cord and relaying them to the Thalamus, and from there to the Cortex, and back again in a feedback loop to the Hippocampus/Thalamus/ Hypothalamus and participating neural structures in order for learning and memory to take place. Without continual excitation of cortical neurons by reticular activation impulses, an individual is unconscious and cannot be aroused. When stimulation is enough for consciousness but not for attentiveness, ADD or LD results. If too activated, an individual cannot relax or... |
 |
Dr. Bob's Guide to Stop ADHD in 18 Days by Robert DeMaria (Author) This how-to guide can rid children and families off medications and detrimental foods - junk foods loaded with sugar, preservatives, dairy products, and trans- fattyacids - so that children and families can enjoy optimal health. "This user-friendly book has the potential of setting families free from the nightmare of ADD, ADHD, and ODD. Using drugs on kids isn't solving the problem. Follow Dr. Bob's directions and witness the change is can bring to you and your loved ones." Bruce West, D.C. Publisher, Health Alert |
 |
Taking Charge of ADHD: The Complete, Authoritative Guide for Parents (Revised Edition) by PhD Russell A. Barkley PhD ABPP ABCN (Author) A treasured parent resource since its publication, Taking Charge of ADHD has now been revised and updated to incorporate the most current information on ADHD and its treatment. From internationally renowned ADHD expert Russell A. Barkley, the book empowers parents by arming them with the up-to-date knowledge, expert guidance, and confidence they need to ensure that their child receives the best care possible. Features of the revised edition include: *A step-by-step plan for behavior management that has helped thousands of children with ADHD *Hard data that clear up current controversies about increased diagnosis and stimulant use *New strategies that give children greater chances of success at school and in social situations *Advances in genetic and neurological research... |
 |
ADD / ADHD Smart Solutions: Ways to Improve Your Child's Behavior Directed By: James Grapek |
 |
Philips GoLite P1 Blue Spectrum Light Therapy Device by Philips Respironics Feel better, faster with the goLITE p1 from Philips. This is the most effective light therapy device on the market today. The goLITE p1 is the result of more than 20 years of clinical studies from leading institutions such as the National Institute of Health, Harvard University, NASA, The Mayo Clinic, etc., on the effectiveness of light therapy. Light therapy is used to treat a variety of disorders relating to the body clock, or circadian rhythm. Exclusive Bluewave Technology has been clinically proven to be twice as effective as white light, and allows the goLITE p1 to be less than half as intense as other light therapy devices. Feel Better. Faster. |
 |
The Survival Guide for Kids with ADD or ADHD by John F. Taylor Ph.D. (Author) What are ADD and ADHD? What does it mean to have ADD and ADHD? How can kids diagnosed with ADD and ADHD help themselves succeed in school, get along better at home, and form healthy, enjoyable relationships with peers? In kid-friendly language and a format that welcomes reluctant and easily distracted readers, Free Spirit's newest survival guide helps kids know they're not alone and offers practical strategies for taking care of oneself, modifying behavior, enjoying school, having fun, and dealing (when needed) with doctors, counselors, and medication. Includes real-life scenarios, quizzes, and a special message for parents. |
 |
Taking Charge of ADHD, Revised Edition: The Complete, Authoritative Guide for Parents by The Guilford Press Raising a child with attention-deficit/hyperactivity disorder is not easy. Bombarded with conflicting medical advice and worn down by the daily frustrations of child care, parents are likely to feel exhaused, confused, and helpless. This much-needed, authoritative book empowers parents of children with ADHD with the knowledge and the confidence they need to ensure their child receives the best care possible. Features include step-by-step methods for managing a child with ADHD in a variety of everyday situations; the latest information on available medications; numerous techniques for enhancing a child's school performance; and a special section devoted to the needs of the parents. |
 |
Driven To Distraction : Recognizing and Coping with Attention Deficit Disorder from Childhood Through Adulthood by Edward M. Hallowell (Author), John J. Ratey (Author) Through vivid stories of the experiences of their patients (both adults and children), Drs. Hallowell and Ratey show the varied forms ADD takes -- from the hyperactive search for high stimulation to the floating inattention of daydreaming -- and the transforming impact of precise diagnosis and treatment. |
| © 2009 BrightSurf.com |